Pneumococcal Disease: A Vaccine Preventable Threat

Translate to Spanish or other 102 languages!

The bottom line: Pneumococcal disease is one of the leading causes of illness among children and seniors. The potentially deadly pneumococcal bacteria causes pneumonia, but it also causes meningitis, sinusitis, sepsis, and ear infections. However, a pneumococcal vaccine can protect both children and adults.

Mega Doctor News

- Advertisement -

As originally published by Mega Doctor News in its newsprint edition June 2018

Patients rarely know it by name, but pneumococcal disease kills more Americans than all other vaccine-preventable diseases combined. “[Pneumococcal bacteria] cause lung infections (pneumonia), brain infections [meningitis], sinusitis, blood infections, and ear infections,” said Dr. Elizabeth C. Knapp, an Austin pediatrician. “Early in my pediatric career, I cared for a 3-year-old girl who had an ear infection — her crying did not improve with the antibiotics [because] the bacteria had spread to her brain.” The bacteria can cause very serious conditions. “People die from pneumococcal diseases,” she said.

Pneumonia is one of the bacteria’s most severe illnesses. According to the U.S. Centers for Disease Control and Prevention (CDC), about 900,000 Americans contract pneumonia each year and as many as 7 percent of those sick enough to be hospitalized die from it.

- Advertisement -

In 2013, 3,700 Americans died from pneumococcal meningitis and bacteremia. Two years later, a 2015 CDC report said 95 percent of pneumococcal deaths in the U.S. were adults. Worldwide, about 500,000 children younger than five die from pneumococcal illnesses each year, making it one of the top killers of young people, according to the World Health Organization.

Symptoms vary depending upon which pneumococcal disease strikes. They include high fever, shortness of breath, headache, nausea, and vomiting. After the disease strikes, the illness can cause hearing loss, brain damage, or death.

Pneumococcal vaccines prevent these complications for both children and adults. Physicians can advise which shot is best for a given patient. A four-dose series is standard for children; a two-dose series is standard for adults.

In the 1940s, physicians believed antibiotics could cure pneumococcal bacterial infections, so there was little call for a vaccine. However, some people still died after treatment. The first vaccine was introduced in 1977, but it did not adequately protect children. However, a childhood vaccine introduced in 2000 has caused a nearly 80-percent drop in invasive pneumococcal disease among U.S. children.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Susie Wiles Announces She Is Cancer-Free Following Breast Cancer Treatment

White House Chief of Staff Susie Wiles announced Wednesday that she is cancer-free following months of treatment for early-stage breast cancer, sharing the news after receiving clear pathology results from the Mayo Clinic.

What You Need to Know About Aortic Dissection

An aortic dissection – a tear in the inner layer of the main artery – is a life-threatening emergency. It can happen with little warning, as apparently was the case with U.S. Sen. Lindsey Graham. His sudden death at age 71 was preliminarily attributed to an aortic dissection stemming from plaque buildup in his arteries.

DHR Health’s Free Seminar on Breakthrough Treatment for Stroke Survivors, Sept. 19th

DHR Health’s Neuroscience Institute will host a free seminar for stroke survivors who want improved hand and arm movement as many stroke survivors experience impaired mobility and loss of function in the arm which can significantly affect their ability to   perform everyday activities.

DHR Health Transplant Success Signals a New Era for Advanced Medicine in the Rio Grande Valley

The significance of DHR Health Transplant Institute’s latest recognition extends far beyond a hospital ranking. It raises a larger question for South Texas: Has the Rio Grande Valley reached the point where patients can look to the region not only for local healthcare, but for nationally competitive transplant medicine?
- Advertisement -